Skip to main content
. 2021 May 3;9(1):e001313. doi: 10.1136/bmjdrc-2020-001313

Figure 3.

Figure 3

Short-term analyses with different time horizons. *Empagliflozin is less costly and more effective than the comparator. ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life year; SoC, standard of care.